This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cell | 1076 |
- | hsct | 959 |
median | age | 657 |
- | transplant | 551 |
- | cells | 399 |
high | risk | 311 |
- | risk | 269 |
immune | response | 269 |
pediatric | patients | 261 |
viral | infections | 236 |
immune | responses | 160 |
hematopoietic | cell | 143 |
- | year | 138 |
specific | t | 132 |
viral | infection | 102 |
- | t | 98 |
high | levels | 93 |
first | year | 83 |
- | transplantation | 75 |
renal | transplant | 70 |
immune | cells | 67 |
higher | risk | 66 |
positive | cells | 64 |
- | tumor | 55 |
renal | transplantation | 55 |
- | group | 53 |
first | case | 52 |
renal | disease | 50 |
severe | infections | 50 |
- | infection | 49 |
primary | infection | 48 |
older | patients | 45 |
immune | cell | 44 |
low | levels | 44 |
higher | levels | 44 |
median | day | 41 |
- | treatment | 40 |
positive | patients | 40 |
overall | response | 39 |
- | analysis | 38 |
- | expression | 38 |
clinical | response | 38 |
high | level | 38 |
renal | cell | 36 |
older | age | 34 |
first | month | 33 |
significant | risk | 33 |
low | risk | 32 |
- | disease | 31 |
first | day | 31 |
human | t | 30 |
other | patients | 28 |
pediatric | patient | 28 |
- | therapy | 28 |
normal | levels | 28 |
first | patient | 28 |
such | patients | 27 |
hematopoietic | cells | 25 |
negative | patients | 25 |
other | studies | 25 |
primary | tumor | 25 |
- | level | 24 |
- | patients | 24 |
clinical | studies | 24 |
normal | t | 24 |
- | virus | 23 |
lower | risk | 23 |
primary | tumors | 22 |
severe | disease | 22 |
- | day | 22 |
higher | expression | 22 |
other | groups | 21 |
other | infections | 21 |
high | expression | 21 |
low | level | 21 |
lower | levels | 20 |
other | patient | 20 |
pediatric | hsct | 20 |
primary | disease | 20 |
- | month | 20 |
acute | infection | 19 |
clinical | study | 19 |
old | patient | 19 |
specific | treatment | 19 |
chronic | infection | 18 |
median | days | 18 |
other | viruses | 17 |
pediatric | transplant | 17 |
- | years | 17 |
different | cell | 16 |
human | disease | 16 |
positive | cases | 16 |
human | cells | 15 |
low | expression | 15 |
other | cases | 15 |
renal | tumors | 15 |
severe | infection | 15 |
- | patient | 14 |
first | study | 14 |
highest | risk | 14 |
negative | group | 13 |
primary | cells | 13 |
positive | results | 13 |
hematopoietic | transplantation | 13 |
low | t | 13 |
- | donor | 13 |
- | response | 13 |
- | methods | 12 |
- | transplanted | 12 |
acute | infections | 12 |
early | disease | 12 |
higher | level | 12 |
pediatric | cases | 12 |
viral | diseases | 12 |
negative | t | 11 |
other | diseases | 11 |
different | levels | 11 |
early | treatment | 11 |
different | treatment | 11 |
human | tumor | 10 |
severe | t | 10 |
severe | cases | 10 |
renal | diseases | 10 |
negative | cases | 10 |
- | p | 10 |
higher | response | 10 |
first | transplant | 10 |
early | hsct | 10 |
clinical | results | 10 |
other | disease | 9 |
such | infections | 9 |
specific | responses | 9 |
renal | tumor | 9 |
other | therapies | 9 |
positive | disease | 9 |
other | day | 9 |
- | infections | 9 |
early | studies | 9 |
clinical | case | 9 |
chronic | disease | 9 |
lower | expression | 9 |
other | cell | 8 |
such | cases | 8 |
specific | cells | 8 |
renal | transplants | 8 |
positive | t | 8 |
multiple | infections | 8 |
immune | therapy | 8 |
first | group | 8 |
early | age | 8 |
- | study | 8 |
normal | level | 7 |
significant | response | 7 |
significant | levels | 7 |
positive | expression | 7 |
positive | donor | 7 |
overall | disease | 7 |
other | tumors | 7 |
other | treatment | 7 |
other | cells | 7 |
primary | treatment | 7 |
negative | results | 7 |
early | transplant | 7 |
clinical | responses | 7 |
different | age | 7 |
clinical | disease | 7 |
negative | cells | 7 |
first | hsct | 7 |
first | results | 7 |
human | infection | 7 |
highest | expression | 6 |
viral | disease | 6 |
such | cells | 6 |
specific | cell | 6 |
significant | infections | 6 |
pediatric | donors | 6 |
median | patient | 6 |
immune | diseases | 6 |
viral | therapy | 6 |
human | diseases | 6 |
high | response | 6 |
first | days | 6 |
early | t | 6 |
different | viruses | 6 |
different | t | 6 |
different | groups | 6 |
- | responses | 6 |
- | groups | 6 |
first | years | 6 |
multiple | studies | 5 |
normal | responses | 5 |
other | donors | 5 |
other | group | 5 |
such | studies | 5 |
pediatric | age | 5 |
positive | tumors | 5 |
primary | t | 5 |
specific | therapy | 5 |
normal | cells | 5 |
other | risk | 5 |
median | cell | 5 |
different | tumor | 5 |
lower | level | 5 |
- | levels | 5 |
different | donors | 5 |
different | patients | 5 |
chronic | diseases | 5 |
first | analysis | 5 |
high | group | 5 |
high | t | 5 |
immune | disease | 5 |
overall | responses | 4 |
multiple | risk | 4 |
multiple | viruses | 4 |
negative | donor | 4 |
normal | donors | 4 |
normal | response | 4 |
older | group | 4 |
other | treatments | 4 |
severe | group | 4 |
positive | cell | 4 |
positive | group | 4 |
positive | patient | 4 |
positive | response | 4 |
median | level | 4 |
significant | transplant | 4 |
specific | risk | 4 |
specific | therapies | 4 |
such | treatment | 4 |
median | treatment | 4 |
normal | results | 4 |
median | donor | 4 |
earlier | studies | 4 |
median | disease | 4 |
- | viruses | 4 |
chronic | infections | 4 |
clinical | cases | 4 |
different | donor | 4 |
different | group | 4 |
different | tumors | 4 |
earlier | age | 4 |
clinical | risk | 4 |
early | results | 4 |
hematopoietic | transplants | 4 |
high | groups | 4 |
higher | cell | 4 |
higher | tumor | 4 |
human | viruses | 4 |
early | therapy | 4 |
low | cells | 4 |
normal | cell | 3 |
older | donors | 3 |
older | donor | 3 |
normal | group | 3 |
normal | expression | 3 |
multiple | treatments | 3 |
non | t | 3 |
multiple | tumors | 3 |
lowest | risk | 3 |
low | response | 3 |
overall | result | 3 |
low | disease | 3 |
significant | results | 3 |
overall | study | 3 |
pediatric | case | 3 |
pediatric | donor | 3 |
positive | case | 3 |
positive | groups | 3 |
positive | tumor | 3 |
severe | case | 3 |
significant | disease | 3 |
significant | treatment | 3 |
specific | disease | 3 |
specific | expression | 3 |
low | group | 3 |
other | transplant | 3 |
low | cell | 3 |
earlier | study | 3 |
immune | donors | 3 |
- | age | 3 |
- | studied | 3 |
acute | disease | 3 |
clinical | expression | 3 |
clinical | groups | 3 |
clinical | methods | 3 |
different | methods | 3 |
different | risk | 3 |
different | transplantation | 3 |
different | treatments | 3 |
acute | response | 3 |
earlier | treatment | 3 |
high | transplant | 3 |
early | response | 3 |
human | tumors | 3 |
human | infections | 3 |
high | tumor | 3 |
highest | level | 3 |
high | cells | 3 |
hematopoietic | transplant | 3 |
first | therapy | 3 |
first | patients | 3 |
first | months | 3 |
pediatric | t | 2 |
oldest | patient | 2 |
pediatric | study | 2 |
overall | hsct | 2 |
other | tumor | 2 |
other | therapy | 2 |
other | t | 2 |
other | case | 2 |
other | age | 2 |
negative | donors | 2 |
old | group | 2 |
normal | % | 2 |
negative | result | 2 |
negative | response | 2 |
negative | expression | 2 |
multiple | treatment | 2 |
median | year | 2 |
pediatric | tumor | 2 |
pediatric | transplantation | 2 |
specific | diseases | 2 |
positive | donors | 2 |
primary | cell | 2 |
viral | expression | 2 |
such | response | 2 |
such | diseases | 2 |
such | disease | 2 |
specific | virus | 2 |
specific | level | 2 |
median | response | 2 |
specific | analysis | 2 |
significant | tumors | 2 |
significant | t | 2 |
significant | level | 2 |
significant | infection | 2 |
significant | age | 2 |
severe | diseases | 2 |
renal | expression | 2 |
primary | patient | 2 |
primary | diseases | 2 |
median | tumor | 2 |
specific | response | 2 |
median | patients | 2 |
first | transplantation | 2 |
early | infection | 2 |
early | case | 2 |
different | therapies | 2 |
different | studies | 2 |
different | response | 2 |
different | patient | 2 |
different | diseases | 2 |
different | disease | 2 |
clinical | treatment | 2 |
clinical | levels | 2 |
clinical | infection | 2 |
acute | t | 2 |
- | studies | 2 |
- | days | 2 |
- | case | 2 |
- | analyses | 2 |
median | levels | 2 |
first | cases | 2 |
different | cells | 2 |
first | treatment | 2 |
human | patients | 2 |
median | group | 2 |
first | virus | 2 |
median | % | 2 |
lower | disease | 2 |
lower | cell | 2 |
low | transplant | 2 |
immune | therapies | 2 |
human | studies | 2 |
median | ages | 2 |
high | cell | 2 |
hematopoietic | diseases | 2 |
human | cases | 2 |
higher | treatment | 2 |
higher | transplant | 2 |
higher | infection | 2 |
high | donor | 2 |
human | cell | 2 |
overall | tumor | 1 |
overall | risk | 1 |
overall | results | 1 |
other | virus | 1 |
overall | infections | 1 |
overall | day | 1 |
pediatric | tumors | 1 |
overall | analysis | 1 |
others | therapies | 1 |
pediatric | ages | 1 |
positive | responses | 1 |
positive | conclusion | 1 |
positive | conclusions | 1 |
positive | infection | 1 |
positive | result | 1 |
positives | cases | 1 |
primary | analysis | 1 |
primary | infections | 1 |
primary | method | 1 |
primary | patients | 1 |
primary | response | 1 |
others | diseases | 1 |
non | transplanted | 1 |
other | transplantation | 1 |
other | study | 1 |
negative | hsct | 1 |
negative | infections | 1 |
negative | patient | 1 |
negative | tumors | 1 |
primary | therapy | 1 |
normal | age | 1 |
normal | conclusions | 1 |
normal | donor | 1 |
normal | patients | 1 |
normal | result | 1 |
old | age | 1 |
old | patients | 1 |
older | patient | 1 |
other | analysis | 1 |
other | donor | 1 |
other | hsct | 1 |
other | infection | 1 |
other | levels | 1 |
other | methods | 1 |
other | responses | 1 |
other | results | 1 |
primary | study | 1 |
specific | cases | 1 |
primary | transplantation | 1 |
renal | infection | 1 |
specific | study | 1 |
such | case | 1 |
such | donors | 1 |
such | expression | 1 |
such | group | 1 |
such | infection | 1 |
such | method | 1 |
such | methods | 1 |
such | results | 1 |
such | therapy | 1 |
such | transplants | 1 |
such | treatments | 1 |
such | tumors | 1 |
such | virus | 1 |
viral | method | 1 |
viral | response | 1 |
viral | results | 1 |
viral | studies | 1 |
viral | t | 1 |
viral | treatment | 1 |
negative | case | 1 |
specific | studies | 1 |
specific | risks | 1 |
specific | patient | 1 |
significant | conclusions | 1 |
renal | therapy | 1 |
severe | groups | 1 |
severe | patients | 1 |
severe | response | 1 |
severe | studies | 1 |
severe | therapy | 1 |
severe | transplant | 1 |
severest | cases | 1 |
significant | cell | 1 |
significant | day | 1 |
specific | infections | 1 |
significant | expression | 1 |
significant | group | 1 |
significant | p | 1 |
significant | responses | 1 |
significant | tumor | 1 |
specific | donor | 1 |
specific | group | 1 |
specific | groups | 1 |
specific | infection | 1 |
negative | cell | 1 |
first | t | 1 |
multiple | virus | 1 |
hematopoietic | hsct | 1 |
different | results | 1 |
different | study | 1 |
different | transplant | 1 |
earlier | disease | 1 |
earlier | transplant | 1 |
earlier | years | 1 |
early | ages | 1 |
early | days | 1 |
early | expression | 1 |
early | months | 1 |
early | risk | 1 |
early | transplantation | 1 |
early | treatments | 1 |
early | tumor | 1 |
early | years | 1 |
first | disease | 1 |
first | infection | 1 |
first | level | 1 |
first | method | 1 |
first | transplants | 1 |
first | tumor | 1 |
different | p | 1 |
different | method | 1 |
different | infections | 1 |
acute | responses | 1 |
- | cases | 1 |
- | diseased | 1 |
- | donors | 1 |
- | grouping | 1 |
- | method | 1 |
- | resulting | 1 |
- | transplants | 1 |
- | tumors | 1 |
acute | patients | 1 |
anti | tumor | 1 |
different | expression | 1 |
anti | virus | 1 |
chronic | t | 1 |
chronic | transplant | 1 |
chronic | treatment | 1 |
clinical | group | 1 |
clinical | infections | 1 |
clinical | t | 1 |
clinical | tumor | 1 |
different | ages | 1 |
hematopoietic | donor | 1 |
hematopoietic | responses | 1 |
multiple | transplants | 1 |
hematopoietic | tumors | 1 |
low | patient | 1 |
low | responses | 1 |
low | result | 1 |
low | treatment | 1 |
low | tumor | 1 |
lower | % | 1 |
lower | results | 1 |
lower | t | 1 |
lower | transplant | 1 |
lower | treatment | 1 |
lowest | expression | 1 |
lowest | expressions | 1 |
median | cells | 1 |
median | risk | 1 |
median | transplantation | 1 |
multiple | case | 1 |
multiple | cell | 1 |
multiple | donors | 1 |
multiple | expression | 1 |
multiple | infection | 1 |
multiple | transplantations | 1 |
low | groups | 1 |
low | donor | 1 |
immune | t | 1 |
higher | expressions | 1 |
high | case | 1 |
high | expressions | 1 |
high | risks | 1 |
high | transplanted | 1 |
high | treatment | 1 |
high | virus | 1 |
higher | % | 1 |
higher | day | 1 |
higher | disease | 1 |
higher | risks | 1 |
immune | studies | 1 |
highest | expressions | 1 |
highest | levels | 1 |
highest | tumor | 1 |
human | donor | 1 |
human | donors | 1 |
human | patient | 1 |
human | virus | 1 |
immune | donor | 1 |
immune | responsing | 1 |
viral | tumor | 1 |